MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial

An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	American cities where house prices are crashing fastest… including four Texas hotspots	🔴 72 / 100
2	Why Justin Baldoni Is Slamming Blake Lively for 'Abuse of Process'	🔴 65 / 100
3	Reconfigured Mets culture is taking over in Queens	🔴 65 / 100
4	NFL hall of famer Shannon Sharpe accused of rape in Nevada lawsuit	🔴 65 / 100
5	King Charles pays tribute to Pope Francis after his death aged 88: His Majesty joins world leaders in remembering 'compassionate and devoted' Pontiff following his 'devastating' passing	🔴 65 / 100
6	Shannon Sharpe’s Net Worth: How Much the Sports Commentator Makes?	🔴 62 / 100
7	Ten women, one guy: The risk-taking dating show that stirred Ethiopia	🔵 55 / 100
8	DHL halts international deliveries to US consumers worth over $800	🔵 55 / 100
9	John Higgins fights through emotional turmoil to ignite Crucible challenge	🔵 45 / 100
10	Malcolm in the Middle star urged to ‘quit’ reboot after sharing health fears in new update	🔵 35 / 100

View More Top News ➡️